Precision Begins at
the Metabolome
100K+
Known Metabolites
500+
Metabolic Pathways
100%
Patient-Centered
Board
Certified Standard
Me·tab·o·lo·mics
/ məˌtabəˈlōmiks / · noun
noun · precision scienceThe large-scale study of small molecules - metabolites within biological systems, providing a real-time biochemical snapshot of cellular function, physiology, and disease state.
Origin
From Latin metabolismus (change) + Greek -ome (complete set). The term emerged in the late 1990s as mass spectrometry and NMR technology enabled comprehensive profiling of the metabolome for the first time.
The Metabolomics Department at the American Board of Precision Medicine harnesses the power of the metabolome to unlock a dynamic, real-time window into patient health equipping clinicians to detect disease earlier, stratify risk more precisely, and monitor therapeutic response at the biochemical level.
From mass spectrometry-based profiling and pathway analysis to lipidomics and biomarker discovery, this department trains physicians to interpret the downstream products of genomic, proteomic, and environmental interactions translating complex biochemical data into actionable clinical decisions.
Because metabolites reflect what is actually happening in the body right now, metabolomics stands as the most functionally immediate layer of the multi-omics stack and at ABOPM, it is taught as an essential pillar of precision diagnostics.
100K+
Known Metabolites
500+
Metabolic Pathways
∞
Clinical Possibilities
Where the Metabolome Meets
Clinical Purpose
The Metabolomics Department at ABOPM exists at the intersection of biochemical science and patient care - training physicians to decode the metabolome, apply its insights, and transform outcomes across every clinical specialty.
Advancing research in untargeted and targeted metabolite profiling, pathway dysregulation, and biomarker identification - deepening our understanding of the biochemical signatures underlying human disease.
Bridging laboratory metabolomics and bedside medicine - developing board-certified frameworks for metabolic risk stratification, nutritional precision medicine, and disease monitoring through biochemical phenotyping.
Building the next generation of metabolomics-fluent clinicians through rigorous board standards, interdisciplinary training, and collaboration across internal medicine, oncology, endocrinology, and molecular science.
"The metabolome is not a snapshot - it is a dynamic portrait of health. The Metabolomics Department at ABOPM trains physicians to interpret that portrait, act on its signals, and deliver care that is truly personalized."
American Board of Precision Medicine · Metabolomics DepartmentTranslating the Metabolome
Into Clinical Impact
The metabolome is the most dynamic, real-time reflection of human physiology ever measured. Learning to read it is not optional for the future of medicine - it is foundational.
Metabolomics equips clinicians to move beyond symptom management and into the biochemical root causes of disease - enabling earlier detection, more precise therapeutic targeting, and care that responds to each patient's unique physiological state in real time.
By mastering metabolomics, clinicians gain the power to:
Why Metabolomics Fluency Is Non-Negotiable
The biochemical data is here. The clinical tools are ready. The question is, are you?
Metabolomics-guided care improves therapeutic precision, reduces trial-and-error prescribing, and enables truly individualized disease prevention and management.
High-throughput metabolomic profiling is now clinically accessible and rapidly entering standard workflows - clinicians who can't interpret it will be left behind.
Board certification in metabolomics establishes you as a recognized leader in precision medicine - differentiating your expertise as biochemical phenotyping becomes standard of care.
Metabolomics connects every specialty: endocrinology, oncology, cardiology, psychiatry, and nutrition medicine giving you tools that transcend clinical silos.
Active research areas driving metabolomic medicine forward:
The metabolomics revolution is not a future event - it is happening now. High-throughput metabolite profiling, pathway-level biomarker discovery, and real-time biochemical phenotyping are actively reshaping how disease is detected, monitored, and treated at the molecular level.
The ABOPM Metabolomics Department positions clinicians at the center of this transformation - equipping them with the scientific literacy, clinical frameworks, and board-certified credentials to lead metabolomic medicine in any specialty.
Meet Our Leadership
Director of Metabolomics —
Paniz Jasbi, PhD
Dr. Jasbi trained in systems biology and mass spectrometry at Arizona State University, where he developed expertise in high-throughput metabolomic profiling and biochemical pathway analysis. His work sits at the intersection of analytical chemistry, clinical science, and precision medicine.
He is Co-Founder and Chief Science Officer of Theriome Inc., where he led development of the Aristotle Test - a metabolomics-based diagnostic platform advancing personalized care. He also serves as Director of Metabolomics at ABOPM and has published extensively in major scientific journals.
His work focuses on translating scientific discoveries in metabolomics into scalable clinical applications that improve health outcomes globally from early disease detection to precision therapeutic monitoring.
Faculty Members
Our faculty roster is growing - announcements coming soon.
Faculty position open
Faculty position open
Faculty position open
Faculty position open
Think you're the right fit for a faculty position?
Get Involved →
Shaping the Future
of Precision Medicine
As precision medicine continues to evolve, genomics will play an increasingly central role in redefining how disease is understood, predicted, and treated at the molecular level.
The Genomics Department at ABOPM remains committed to advancing this field through scientific leadership, clinical innovation, and collaborative discovery. Together with our global community of physicians and researchers, we are helping shape the future of next-generation healthcare.
Insights Shaping
Precision Medicine
Explore ABOPM perspectives on genomics, multi-omics, systems thinking, clinical innovation, and the future of physician leadership in precision medicine.
Precision Medicine in Oncology Isn’t the Future - It’s Already Late
Precision medicine in oncology is no longer a distant vision- it is a critical necessity. As cancer care evolves, biomarker-driven diagnostics, genomic sequencing, digital pathology, and AI-powered in... ...more
Precision Oncology
May 17, 2026•4 min read
Pharmacogenomics in Clinical Practice: Prescribing the Right Drug the First Time
Helping clinicians understand how genetic variation influences drug response ...more
Precision Medicine in Action
May 13, 2026•9 min read
Tumor Genomic Profiling: When Should It Be Used in Clinical Practice?
Tumor genomic profiling helps identify actionable mutations to guide targeted therapies and clinical decisions. Understanding when to use it is key to maximizing its impact in precision oncology. ...more
Precision Oncology
May 07, 2026•8 min read
Stay at the Forefront of Precision Medicine
Subscribe to receive ABOPM insights, research updates, and educational resources delivered directly to your inbox.
Advancing education, certification, and leadership to shape a genomics-driven, data-intelligent future of healthcare.
COMPANY
RESOURCES
© 2023-2025 American Board of Precision Medicine, Inc. All Rights Reserved.